Rootine is a technology company.
Rootine has raised $13.0M across 2 funding rounds.
Rootine has raised $13.0M in total across 2 funding rounds.
Rootine is a Nashville-based health tech company that builds personalized nutrition solutions, including smart multivitamins and functional supplements, using at-home lab tests (DNA, blood, lifestyle), AI algorithms, and slow-release microbead technology. It serves consumers seeking optimized health—particularly for stress, fatigue, sleep, mood, and circadian rhythms—solving the problem of one-size-fits-all vitamins by delivering data-driven, individualized micronutrient doses backed by nutrigenetic science and over 400 peer-reviewed studies[1][2][3][4][5][7]. Targeting the $700 billion personalized nutrition market, Rootine has shown early momentum with a $3 million seed round and a subscription model sending monthly 30-day vitamin packs[1][3].
Rootine was co-founded by Rachel Sanders, an ex-investment banker, Harvard Business School MBA, and one of the few female founders in data-driven health, and Dr. Daniel Wallerstorfer, a PhD biotechnician, nutrigenetic expert, and founder of Europe’s leading genetics lab. Both were combating personal stress and fatigue—Sanders post-business school, Wallerstorfer from his lab work—leading them to reject conventional nutrition and develop precision solutions[1][5]. They connected via a mutual mentor at Techstars, uniting to commercialize Wallerstorfer’s precision nutrition tech with Sanders’ entrepreneurial drive, launching Rootine in Nashville to empower data-leveraged health optimization[5].
Rootine rides the personalized nutrition and circadian health trend, fueled by consumer access to personal data (DNA tests, wearables) amid modern disruptions like screen time and irregular schedules that misalign the body’s 24-hour rhythms regulating metabolism, immunity, and stress. Timing aligns with post-2017 Nobel validation of circadian research and the booming $700B market’s shift from generic supplements to precision tech[1][6][7]. Market forces like quantified-self tech and demand for trackable outcomes favor Rootine, influencing the ecosystem by pioneering data-science integration in wellness, lowering medical-grade testing costs, and inspiring female-led innovation in male-dominated health tech[1][2][5].
Rootine is poised to expand its circadian-focused portfolio—blending vitamins, functional drinks, and real-time tracking—amid rising demand for proactive, data-backed wellness in a post-pandemic world prioritizing mental health and performance. Trends like AI-driven nutrigenomics, wearable ecosystems, and subscription health will accelerate growth, potentially scaling via B2B partnerships or global reach from its Techstars roots. Its scientist-CEO synergy and commitment to evidence-based personalization position it to redefine daily health routines, empowering users toward vibrant, optimized lives from the inside out.
Rootine has raised $13.0M in total across 2 funding rounds.
Rootine's investors include Catalio Capital, Refactor Capital, Amjad Masad, Anne Wojcicki, Balaji Srinivasan, Dylan Field, Fidji Simo, Varsha Rao, DVC, Andy Coravos.
Rootine has raised $13.0M across 2 funding rounds. Most recently, it raised $10.0M Series A in September 2022.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Sep 1, 2022 | $10.0M Series A | Catalio Capital, Refactor Capital, Amjad Masad, Anne Wojcicki, Balaji Srinivasan, Dylan Field, Fidji Simo, Varsha Rao | |
| Aug 1, 2021 | $3.0M Seed | DVC, Andy Coravos |